Literature DB >> 11328682

Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents.

S A Santi1, L L Cook, M A Persinger, R P O'Connor.   

Abstract

Within 30 min after the initiation of status epilepticus (SE) by lithium and pilocarpine, rats were injected with either acepromazine or ketamine. Compared to the rats that had received the acepromazine, the group that had received the ketamine displayed more accurate spatial memory. Their scores did not differ significantly from normal (non-seized) controls. Although the ketamine treatment did not significantly change the amount of neuronal loss within about 100 Paxinos and Watson structures, it was neuroprotective for several structures within the thalamus and portions of the temporal and parietal cortices. Ketamine-treated rats, however, displayed markedly more damage within the entorhinal cortices and amygdalohippocampal area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328682     DOI: 10.3109/00207450109149757

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Status epilepticus: current treatment strategies.

Authors:  Edward M Manno
Journal:  Neurohospitalist       Date:  2011-01

2.  Activation of the phagocyte NADPH oxidase/NOX2 and myeloperoxidase in the mouse brain during pilocarpine-induced temporal lobe epilepsy and inhibition by ketamine.

Authors:  Fatma Tannich; Asma Tlili; Coralie Pintard; Amina Chniguir; Bruno Eto; Pham My-Chan Dang; Ouajdi Souilem; Jamel El-Benna
Journal:  Inflammopharmacology       Date:  2019-10-30       Impact factor: 4.473

3.  A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat.

Authors:  Tamara Modebadze; Nicola H Morgan; Isabelle A A Pérès; Rebecca D Hadid; Naoki Amada; Charlotte Hill; Claire Williams; Ian M Stanford; Christopher M Morris; Roland S G Jones; Benjamin J Whalley; Gavin L Woodhall
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.